A blood sugar log that bought 40k installs in a week: how an Indian app factory stormed the Gulf health charts

On Google Play there's an app called "Blood Sugar Care: BP Tracker". It launched 1, had only about a hundred installs by late October, and by 6 November it had 41k, ranking #10 in the health & fitness free charts in the UAE and Saudi Arabia. It has not a single rating. Its name nearly copies a 25M-install hit, and behind it is a cluster of studios in Gujarat that mass-produce utility apps. Below: how it got going, where the money comes from, what gaps remain in this category, and why it's worth understanding but not worth copying.

A video with 1,600 views

On 2026 October 23 at 3:46 p.m., a personal Facebook profile called "Lý Lệ" posted a vertical video with an English title: "Your Body Sends Signals Every Day — Are You Listening?" Below the video was not the person's own product but an app link: Blood Sugar Care: BP Tracker. By 6 November, the video had 1,600 views and 2 likes.

The profile name is Vietnamese, the category is "Reel creator" / "Gaming video creator", and it has nothing to do with blood sugar. This is a common way these studios buy traffic: borrowed or purchased personal accounts post links and run Meta ads (inferred). A week or so later, the app's install count started climbing.

What it is

A manual logbook. The store page is clear: you measure with your own glucometer or BP monitor, enter the numbers, and it stores them, charts them by day / week / month, and lets you share them with your doctor. It logs blood sugar (fasting, before meals, after meals, bedtime; supports mg/dL and mmol/L), systolic / diastolic pressure and pulse, medication reminders, plus "large text, log an entry in a few taps". Free, with ads, no in-app purchases.

The store page ends with a bolded "Important" note: this is not a medical device, it doesn't measure blood sugar, blood pressure or heart rate, it only stores numbers you enter by hand. This note matters, we'll come back to it.

How the 40k installs happened

Start with the numbers (third-party install estimate; the Google Play store page for 11-06 shows "10K+"):

Mid-to-late October it was single digits a day, then Nov 1 it jumped, and since then it's been 7,000 to 10,000+ a day, +41k a week. At the same time 0 ratings, 0 reviews: forty thousand people installed it and not one rated it. Users who find an app organically almost always leave some review, so a curve like this plus a 0 rating basically says the volume was bought and the intent is low (inference). What's visible is the Meta video above; whether Google app ads were run can't be checked from outside, unverified.

After it took off, it charted in the Health & Fitness Top Free chart in 18 countries. 11-06 rankings: UAE 10, Saudi Arabia 10, Italy 33, Singapore 33, Turkey 35, Malaysia and Vietnam 51, Sweden and the Philippines 58, Germany 60, India 63, UK 114. It never charted in the US.

Why could +40k a week get it into the UAE top 10? Because the Gulf health category charts have a very low bar. On the same day, in the UAE chart's top 15, other apps had weekly installs ranging from a few thousand to millions (Google's own Health Connect was +3.14M a week). Its volume was spread across a dozen-plus countries, none of them large, but in the low-bar markets it was just enough to reach the chart. Once charted, it picked up a bit more chart exposure and search exposure.

Who's behind it

The developer name on the store page is CabTech International, the address is a factory unit in Phase 3 of the GIDC industrial area in Jamnagar, the phone is a UK number, and the support email is a personal gmail. Online, a company with this name at this address is an LPG valve manufacturer founded in 2021 (Justdial, LinkedIn). This developer account only became active 2026 years ago, has just two apps, the other being an AI photo editor. A valve factory doesn't look like the kind of place that builds a blood sugar app itself; it's more likely an organizational account opened under a real company's name (inference, unverified).

The lead is in the developer website field: qtonzdev.in. The same domain is also attached to other developer accounts, such as Nikita Infotech's screen-mirroring app (5 weekly 1.03M installs), a GPS app and a caller-ID app. "Qtonz" is an outsourcing and in-house app studio in Rajkot founded around 2012 years ago; the related QZEE GAMES LLP was registered in 2024, and at least 12 developer accounts using its domain published, in a dense run from 7 through September of 2026, apps for satellite maps, WiFi, screen mirroring, short drama, palm reading, IPTV and PDF, many with hundreds of thousands of installs and 0 ratings (company registration data from zaubacorp and tracxn).

In other words, this isn't one developer that built one app. It's a factory opening a new package: several accounts and package names per category, each buying a week of volume, watching retention and ad revenue, scaling what works and dropping what doesn't.

Who it copied from

It copied PRK APPS LLP's "Blood Sugar Care: BP Monitor," differing only in the last word of the title (Monitor swapped for Tracker). 25.4M installs, still +68k that week 11-06. PRK APPS is also in Rajkot.

The three most-liked reviews on that older hit's store page all say the same thing:

"It calls itself a 'blood pressure monitor,' and only after you install it do you find out it isn't. You have to measure with a real BP cuff and type the numbers in. Assuming you can get past the ads, many of which are designed to look like the app's own buttons." — Melissa, Google Play, 2026-08-26,156 people found this helpful

"The ad says you can measure with your phone. You can't. Pure clickbait." — Alien, Google Play, 2026-09-26,89 people found this helpful

"Stuck on the language selection page, probably because of the ads. Now it's just a scam that squeezes ad impressions." — The MythMaker, Google Play, 2026-08-29,250 people found this helpful

Rating 3.9. Users are lured in by ads promising "measure blood pressure with your phone," find it's just a logbook, and then get driven off by a screen full of ads. CabTech's new package puts "not a medical device, does not measure" in the most prominent spot on the store page, which is a lesson learned: safer on compliance and less likely to be delisted, but the functionality is identical to the template.

Where the money comes from

It's ads only. The users are chronically ill middle-aged and older people and the family members who log numbers for them. If they actually use it, they open it every day, so retention is naturally better than a typical utility, and interstitials and banners can pay back day by day. Ad rates in the Gulf and Europe are higher than in South Asia, which may also explain why it targeted those countries (inference). Revenue isn't public, and how much was spent on acquisition and whether it paid back is unknown.

Who it's competing with

How crowded it is: on Google Play, apps published in the last 2026 years with blood / glucose / BP / diabetes in their names total 50.5M installs across 56 apps, and gained +7M in the last 1.45 days combined.

It's a follower itself: in the same period there was also "BP Glucose Health Tracker," launched in October 15 and gaining +58k a week, and "Blood Sugar & Diabetes Tracker," launched in September 30, using the same playbook. Few people know it; there's no discussion on X, TikTok or Reddit. But in the utility-app crowd, everyone knows this category is a red ocean.

If it were you

C: Worth learning from, not really worth chasing. The need is real: tens of millions of installs have shown that middle-aged and older people want to log blood sugar and blood pressure. But this slot is already the home turf of the Indian factories, dozens of packages competing with the same template and the same acquisition method. New entries win on account matrices and ad budgets, not product.

Who it suits: small studios that already run utility-shell apps, have organizational developer accounts, know how to run Meta or Google app ads, and can afford a test budget of a few thousand dollars a week (estimate). Two things are useful for you: on the Gulf health chart, a few tens of thousands a week is enough to reach the top 10, which can serve as cold-start exposure; and chronic-condition logging has high retention, which suits pure ad monetization.

Who it doesn't suit: indie developers hoping to slowly build users with one product. The features can be written in a week, the moat is zero, and organic search spots are held by veterans from four or five years ago and by templates with tens of millions of installs. Without paid acquisition, a new package is invisible.

How to do it: if you must enter, don't make the 57th English logbook. Do the parts these factories don't do well. The template's negative reviews are clear: users hate "the ad says you can measure, but you can't" and "ads disguised as buttons." An honest logbook with restrained ads, large text, one-tap export for doctors, and the ability to read BP and glucose readings synced from Health Connect, plus a local language these factories ignore (inference: markets like Arabic, Turkish or Vietnamese, where they only made English store pages), can slowly climb organic search through ratings and word of mouth. This path is slow, ad revenue is thin, and you need to be ready for that.

How to acquire users: the factories' playbook is Meta short videos with generic "your body sends signals" hooks, plus cheap-country buys. If you want the honest version, make the creative say "log it in one tap after measuring, show your doctor at month end," target adult children logging numbers for their parents, and put "does not measure, only records" at the top of the store page. The trade-off is fewer one-star reviews.

Is there a window? No obvious one. This slot has no platform loophole to exploit and won't suddenly close; it will only get more crowded.

What would show this read was wrong: (1) Installs keep rising for weeks after this app stops buying and ratings start appearing, which would mean Gulf chart placement and search really do deliver organic volume and the cold-start play is better than it looks; (2) Google Play starts mass-delisting health apps whose titles say Monitor but don't measure, clearing out the template class and opening room for an honest logbook; (3) The reverse: installs drop to a few hundred a day in mid-November and never recover, which would mean this was just a test buy, it didn't pencil out, and even the factory gave up on this slot.

---

Data and sources: Google Play store page (11-06, including store description, developer address and contact info, and reviews of similar apps); Google Play free Health & Fitness charts by country (10-30 through 11-06); install curves are third-party estimates; Facebook video page (Lý Lệ, 10-23); AppBrain developer page; Justdial (CabTech International, Jamnagar); zaubacorp, falconebiz (QZEE GAMES LLP); qtonz.com, tracxn (Qtonz). Where "inference" or "unverified" is written, the claim is an inference or unverified.